Objective To investigate the aetiology, subsequent preventive strategies and outcomes of
stroke despite anticoagulation in patients with atrial fibrillation (AF). Methods We analysed …

Background The optimal approach for cancer screening after an ischemic stroke remains
unclear. Aims We sought to summarize the existing evidence regarding the frequency and …

Patients with hematological diseases often experience cerebrovascular complications
including ischemic stroke, intracerebral and subarachnoid hemorrhage, microbleeds …

Polycythemia vera (PV) is a myeloproliferative disorder associated with an increased risk of
cerebrovascular diseases. In this narrative review, we aimed to analyze the relationships …

Background: Undetermined stroke etiology hampers optimal secondary prevention in a
large proportion of young patients. We explored whether genetic screening for clonal …

Aim: The aim of the present study was to clarify the association between the Janus kinase 2
(JAK2) V617F mutation and large cerebral artery disease (LCAD) in patients with …

Introduction: Patients with cancer are known to have an increased risk of ischemic stroke (IS)
around the time of their diagnosis. However, there is a paucity of data in Asian populations …

Background Philadelphia chromosome-negative myeloproliferative neoplasms (Ph-negative
MPNs) are linked with various complications, notably ischemic stroke. The study aims to …

The term Sneddon's syndrome (SS) has been used since 1965 to describe a vasculopathy
characterized by a combination of cerebrovascular disease with livedo racemosa. SS may …

Background: Essential thrombocythemia (ET) is a subtype of myeloproliferative neoplasm
associated with an increased risk of thrombohemorrhagic complications such as stroke …